Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules

Pediatric Infectious Disease Journal

Volumn 33, Issue SUPPL. 2, 2014, Pages

  Loo, Jennifer D ^a   Conklin, Laura ^a   Knoll, Maria Deloria ^b   Fleming Dutra, Katherine E ^a,c   Park, Daniel E ^b   Kirk, Jennifer ^d   Johnson, T Scott ^e   Goldblatt, David ^f   O'Brien, Katherine L ^b   Whitney, Cynthia G ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d WESTAT   (United States)

^e Biostatistics Unit   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Immunization schedule; Methods; Pneumococcal conjugate vaccine; Systematic review

Indexed keywords

PNEUMOCOCCUS VACCINE;

ASIA; EUROPE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; NASOPHARYNX; NORTH AMERICA; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

CHILD, PRESCHOOL; DATA MINING; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 84891396415     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000085     Document Type: Review

References (11)

1. O'Brien KL, Wolfson LJ, Watt JP, et al.; Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893-902.
2. World Health Organization. Estimated Hib and pneumococcal deaths for children under 5 years of age, 2008. March 14, 2012. Available at: http://www.who.int/immunization-monitoring/burden/Pneumo-hib-estimates/en/index. html. Accessed March 18, 2013.
3. European Medicines Agency. Prevenar. 2011. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/ 000323/human-med-000987.jsp&jsenabled=true. Accessed March 12, 2012.
4. European Medicines Agency. Prevenar 13. 2013. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/ 001104/human-med-001220.jsp&mid=WC0b01ac058001d124. Accessed March 12, 2012.
5. European Medicines Agency. Synflorix. 2011. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/ 000973/human-med-001071.jsp&mid=WC0b01ac058001d124. Accessed March 12, 2012.
6. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization -WHO position paper. Wkly Epidemiol Record. 2007;12:93-104.
7. Conklin L, Loo JD, Kirk J, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J. 2014;33 (Suppl 2):S109-S118.
8. Fleming-Dutra KE, Conklin L, Loo JD, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage. Pediatr Infect Dis J. 2014;33 (Suppl 2):S152-S160.
9. Deloria Knoll M, Park D, Johnson TS, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity. Pediatr Infect Dis J. 2014;33 (Suppl 2):S119-S129.
10. Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J. 2014;33 (Suppl 2):S140-S151.
11. Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33 (Suppl 2):S161-S171.